BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

431 related articles for article (PubMed ID: 4454040)

  • 1. Thrombin interaction with human platelets. Potentiation of thrombin-induced aggregation and release by inactivated thrombin.
    Phillips DR
    Thromb Diath Haemorrh; 1974 Sep; 32(1):207-15. PubMed ID: 4454040
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Plasmin inhibition of thrombin-induced platelet aggregation.
    Miller JL; Katz AJ; Feinstein MB
    Thromb Diath Haemorrh; 1975 Apr; 33(2):286-309. PubMed ID: 124475
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Platelet interaction with polymerizing fibrin.
    Niewiarowski S; Regoeczi E; Stewart GJ; Senyl AF; Mustard JF
    J Clin Invest; 1972 Mar; 51(3):685-99. PubMed ID: 4622107
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro and in vivo functions of thrombin-treated platelets.
    Reimers HJ; Kinlough-Rathbone RL; Cazenave JP; Senyi AF; Hirsh J; Packham MA; Mustard JF
    Thromb Haemost; 1976 Feb; 35(1):151-66. PubMed ID: 785686
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of phospholipase inhibitor mepacrine on platelet aggregation, the platelet release reaction and fibrinogen binding to the platelet surface.
    Winocour PD; Kinlough-Rathbone RL; Mustard JF
    Thromb Haemost; 1981 Jun; 45(3):257-62. PubMed ID: 7281105
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of amino sugars on platelet aggregation and on fibrinogen binding.
    Kinlough-Rathbone RL; Packham MA; Mustard JF
    Thromb Haemost; 1984 Aug; 52(1):75-80. PubMed ID: 6495268
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Concentration effects of platelets, fibrinogen and thrombin on platelet aggregation and fibrin clotting.
    Chao FC; Tullis JL; Kenney DM; Conneely GS; Doyle JR
    Thromb Diath Haemorrh; 1974 Sep; 32(1):216-31. PubMed ID: 4454041
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects on platelet function of removal of platelet sialic acid by neuraminidase.
    Greenberg J; Packham MA; Cazenave JP; Reimers HJ; Mustard JF
    Lab Invest; 1975 Apr; 32(4):476-84. PubMed ID: 1127870
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pretreatment of human platelets with plasmin inhibits responses to thrombin, but potentiates responses to low concentrations of aggregating agents, including the thrombin receptor activating peptide, SFLLRN.
    Kinlough-Rathbone RL; Perry DW; Rand ML; Packham MA
    Thromb Haemost; 1997 Apr; 77(4):741-7. PubMed ID: 9134653
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential effects of cytochalasin B on platelet release, aggregation and contractility: evidence against a contractile mechanism for the release of platelet granular contents.
    Kirkpatrick JP; McIntire LV; Moake JL; Cimo PL
    Thromb Haemost; 1980 Feb; 42(5):1483-9. PubMed ID: 6892735
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The in-vitro effect of tirofiban, glycoprotein IIb/IIIa antagonist, on various responses of porcine blood platelets.
    Ciborowski M; Tomasiak M; Rusak T; Winnicka K; Dobrzycki S
    Blood Coagul Fibrinolysis; 2008 Sep; 19(6):557-67. PubMed ID: 18685439
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 2-(2-Br-phenyl)-8-methoxy-benzoxazinone (HPW-RX2), a direct thrombin inhibitor with a suppressive effect on thromboxane formation in platelets.
    Wu CC; Wang TW; Wang WY; Hsieh PW; Wu YC
    Eur J Pharmacol; 2005 Dec; 527(1-3):37-43. PubMed ID: 16313903
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of suprofen, an inhibitor of prostaglandin biosynthesis, on platelet function, plasma coagulation and fibrinolysis. I. In vitro experiments.
    De Clerck F; Vermylen J; Reneman R
    Arch Int Pharmacodyn Ther; 1975 Aug; 216(2):263-79. PubMed ID: 1180617
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Binding of aggregated immunoglobulins to the human platelet Fc receptors: a mechanism of platelet to platelet bridging.
    Parbtani A; Clark WF; Caveney A; Reid B
    Thromb Haemost; 1987 Dec; 58(4):966-70. PubMed ID: 3127922
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Influence of benzamidine derivatives on thrombin-induced platelet reactions.
    Glusa E; Hoffmann A; Markwardt F
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1982; 109(1):98-106. PubMed ID: 6177615
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of human platelets separated from blood by ADP-induced aggregation.
    Mohammad SF; Reddick RL; Mason RG
    Am J Pathol; 1975 Apr; 79(1):81-94. PubMed ID: 1124800
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Indapamide inhibits human platelet aggregation in vitro: comparison with hydrochlorothiazide.
    Rendu F; Bachelot C; Molle D; Caen J; Guez D
    J Cardiovasc Pharmacol; 1993; 22 Suppl 6():S57-63. PubMed ID: 7508063
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Crovidisin, a collagen-binding protein isolated from snake venom of Crotalus viridis, prevents platelet-collagen interaction.
    Liu CZ; Huang TF
    Arch Biochem Biophys; 1997 Jan; 337(2):291-9. PubMed ID: 9016825
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Deaggregation of human platelets aggregated by thrombin.
    Kinlough-Rathbone RL; Perry DW; Packham MA; Mustard JF
    Thromb Haemost; 1985 Feb; 53(1):42-4. PubMed ID: 2986309
    [TBL] [Abstract][Full Text] [Related]  

  • 20. gammaA/gamma' fibrinogen inhibits thrombin-induced platelet aggregation.
    Lovely RS; Rein CM; White TC; Jouihan SA; Boshkov LK; Bakke AC; McCarty OJ; Farrell DH
    Thromb Haemost; 2008 Nov; 100(5):837-46. PubMed ID: 18989528
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.